JP2009516501A5 - - Google Patents

Download PDF

Info

Publication number
JP2009516501A5
JP2009516501A5 JP2008532468A JP2008532468A JP2009516501A5 JP 2009516501 A5 JP2009516501 A5 JP 2009516501A5 JP 2008532468 A JP2008532468 A JP 2008532468A JP 2008532468 A JP2008532468 A JP 2008532468A JP 2009516501 A5 JP2009516501 A5 JP 2009516501A5
Authority
JP
Japan
Prior art keywords
risk
distant metastasis
patient
distant
expression profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008532468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009516501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/037203 external-priority patent/WO2007038402A1/en
Publication of JP2009516501A publication Critical patent/JP2009516501A/ja
Publication of JP2009516501A5 publication Critical patent/JP2009516501A5/ja
Pending legal-status Critical Current

Links

JP2008532468A 2005-09-22 2006-09-22 鼻咽腔癌の予後的サブクラスの同定のための遺伝子発現プロファイリング Pending JP2009516501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71917105P 2005-09-22 2005-09-22
US72112905P 2005-09-28 2005-09-28
PCT/US2006/037203 WO2007038402A1 (en) 2005-09-22 2006-09-22 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas

Publications (2)

Publication Number Publication Date
JP2009516501A JP2009516501A (ja) 2009-04-23
JP2009516501A5 true JP2009516501A5 (enExample) 2011-01-06

Family

ID=37596251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532468A Pending JP2009516501A (ja) 2005-09-22 2006-09-22 鼻咽腔癌の予後的サブクラスの同定のための遺伝子発現プロファイリング

Country Status (13)

Country Link
US (1) US7998674B2 (enExample)
EP (1) EP1934862A1 (enExample)
JP (1) JP2009516501A (enExample)
KR (1) KR20080063343A (enExample)
CN (2) CN102346816B (enExample)
AU (1) AU2006294880A1 (enExample)
BR (1) BRPI0616139A2 (enExample)
CA (1) CA2623403A1 (enExample)
IL (1) IL190253A0 (enExample)
NO (1) NO20081925L (enExample)
RU (1) RU2008115113A (enExample)
TW (1) TW200729050A (enExample)
WO (1) WO2007038402A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008058018A2 (en) 2006-11-02 2008-05-15 Mayo Foundation For Medical Education And Research Predicting cancer outcome
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9684001B2 (en) 2008-02-07 2017-06-20 Ranju Ralhan Biomarkers for head-and-neck cancers and precancers
CA2618163A1 (en) 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
WO2010030167A2 (en) * 2008-09-12 2010-03-18 Cancer Research Initiative Foundation Method of detection and diagnosis of oral and nasopharyngeal cancers
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) * 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
GB2512153B (en) * 2008-11-17 2014-11-12 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
JP6078339B2 (ja) 2009-05-07 2017-02-08 ベラサイト インコーポレイテッド 甲状腺状態の診断のための方法および組成物
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
WO2011116380A2 (en) 2010-03-19 2011-09-22 H. Lee Moffitt Cancer Center And Research Institute, Inc. Hybrid model for the classification of carcinoma subtypes
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
WO2013090620A1 (en) 2011-12-13 2013-06-20 Genomedx Biosciences, Inc. Cancer diagnostics using non-coding transcripts
CN102732484B (zh) * 2012-07-10 2015-04-22 广东医学院 一种人鼻咽癌肿瘤干细胞系建立方法
ES2945036T3 (es) 2012-08-16 2023-06-28 Veracyte Sd Inc Pronóstico del cáncer de próstata mediante biomarcadores
CN103020454A (zh) * 2012-12-15 2013-04-03 中国科学院深圳先进技术研究院 发病关键因素提取与疾病预警方法及系统
KR101711584B1 (ko) * 2012-12-18 2017-03-02 재단법인 의약바이오컨버젼스연구단 변형된 eprs 단백질의 결정 구조 및 이의 결정화 방법
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3770274A1 (en) 2014-11-05 2021-01-27 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
US11414708B2 (en) 2016-08-24 2022-08-16 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
AU2018210695B2 (en) 2017-01-20 2024-07-18 The University Of British Columbia Molecular subtyping, prognosis, and treatment of bladder cancer
US11873532B2 (en) 2017-03-09 2024-01-16 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
CN109801680B (zh) * 2018-12-03 2023-02-28 广州中医药大学(广州中医药研究院) 基于tcga数据库的肿瘤转移复发预测方法及系统
CN111382217B (zh) * 2018-12-29 2025-06-24 北京奇虎科技有限公司 一种目的地推荐方法和装置
CN120473159B (zh) * 2025-07-14 2025-09-26 泛肽生物科技(浙江)有限公司 一种鼻咽癌远处转移预测模型的构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1353947A2 (en) 2000-12-08 2003-10-22 Ipsogen Gene expression profiling of primary breast carcinomas using arrays of candidate genes
WO2002101560A1 (en) * 2001-06-12 2002-12-19 Cross Media Marketing Corp. System and method for traffic management
GB0201498D0 (en) * 2002-01-23 2002-03-13 Biotech Res Ventures Pte Ltd Materials and methods for treating cancer
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation
CN1482256A (zh) * 2002-09-13 2004-03-17 中南大学 鼻咽癌分子标志物—brd7试剂盒
CN1445546A (zh) * 2003-01-08 2003-10-01 中山大学肿瘤防治中心 鼻咽癌早期诊断试剂盒

Similar Documents

Publication Publication Date Title
JP2009516501A5 (enExample)
Wu et al. A novel autophagy‐related lncRNA survival model for lung adenocarcinoma
Mathur et al. Gene set analysis methods: a systematic comparison
Yan et al. Novel fusion transcripts associate with progressive prostate cancer
Frost Variance-adjusted Mahalanobis (VAM): a fast and accurate method for cell-specific gene set scoring
CN111742059B (zh) 用于靶向测序的模型
Liao et al. Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Feng et al. Disease prediction by cell-free DNA methylation
JP2009523028A5 (enExample)
Lin et al. Alignment and classification of time series gene expression in clinical studies
JP2019521673A (ja) 疾患および状態の分析のためのセルフリーdnaメチル化パターン
AU2016291558A1 (en) Markers of stroke and stroke severity
RU2008115113A (ru) Профилирование генной экспрессии для идентификации прогностических субклассов при карциноме носоглотки
CN105102637B (zh) 提取胰腺癌诊断生物标志物的方法、用于该方法的计算装置、胰腺癌诊断生物标志物以及包含该生物标志物的胰腺癌诊断装置
KR20120105444A (ko) 염증성 질병의 활성 측정 및 모니터링을 위한 바이오마커 및 방법
CA3122110A1 (en) Anomalous fragment detection and classification
US20250118439A1 (en) Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
CN107679367A (zh) 一种基于网络节点关联度的共调控网络功能模块识别方法及系统
Grimes et al. Predicting survival times for neuroblastoma patients using RNA-seq expression profiles
Li et al. TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs
Chung et al. Recent technologies towards diagnostic and therapeutic applications of circulating nucleic acids in colorectal cancers
Widman et al. Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
Wang et al. Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma
Koo et al. Prediction of tumor purity from gene expression data using machine learning
Lin et al. Cross-platform prediction of gene expression signatures